Exercise as a Supportive Measure for Patients Undergoing Checkpoint-inhibitor Treatment
NCT03171064
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
39
Enrollment
OTHER
Sponsor class
Conditions
PD-1 Antibodies
Exercise
Melanoma
Interventions
BEHAVIORAL:
Resistance and Endurance Exercise
Sponsor
University Hospital Heidelberg